|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 125, Issue 3 431-442, Copyright © 1998 by Company of Biologists
JOURNAL ARTICLES |
A Frisch and CV Wright
Department of Cell Biology, Vanderbilt University Medical School, Nashville, TN 37232-2175, USA.
Bone Morphogenetic Proteins (BMPs) are potent regulators of embryonic cell fate that are presumed to initiate signal transduction in recipient cells through multimeric, transmembrane, serine/threonine kinase complexes made up of type I and type II receptors. BMPRII was identified previously in mammals as the only type II receptor that binds BMPs, but not activin or TGFbeta, in vitro. We report the cloning and functional analysis in vivo of its Xenopus homolog, XBMPRII. XBMPRII is expressed maternally and zygotically in an initially unrestricted manner. Strikingly, XBMPRII transcripts then become restricted to the mesodermal precursors during gastrulation. Expression is lower in the dorsal organizer region, potentially providing a mechanism to suppress the actions of BMP4 on dorsally fated tissues. Similar to the results seen for a truncated type I BMP receptor (tBR), a dominant-negative form of XBMPRII (tBRII) can dorsalize ventral mesoderm, induce extensive secondary body axes, block mesoderm induction by BMP4 and directly neuralize ectoderm, strongly suggesting that XBMPRII mediates BMP signals in vivo. However, although both tBRII and tBR can induce partial secondary axes, marker analysis shows that tBRII-induced axes are more anteriorly extended. Additionally, coinjection of tBRII and tBR synergistically increases the incidence of secondary axis formation. A truncated activin type II receptor (deltaXAR1) is known to block both activin and BMP signaling in vivo. Here we show that such crossreactivity does not occur for tBRII, in that it does not affect activin signaling. Furthermore, our studies indicate that the full-length activin type II receptor (XAR1) overcomes a block in BMP4 signaling imposed by tBRII, implicating XAR1 as a common component of BMP and activin signaling pathways in vivo. These data implicate XBMPRII as a type II receptor with high selectivity for BMP signaling, and therefore as a critical mediator of the effects of BMPs as mesodermal patterning agents and suppressors of neural fate during embryogenesis.
This article has been cited by other articles:
|
|
 |
|
  Z. Wen, L. Han, J. R. Bamburg, S. Shim, G.-l. Ming, and J. Q. Zheng BMP gradients steer nerve growth cones by a balancing act of LIM kinase and Slingshot phosphatase on ADF/cofilin J. Cell Biol., October 3, 2007; 178(1): 107 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Pouliot, A. Blais, and C. Labrie Overexpression of a Dominant Negative Type II Bone Morphogenetic Protein Receptor Inhibits the Growth of Human Breast Cancer Cells Cancer Res., January 15, 2003; 63(2): 277 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Xanthos, M. Kofron, Q. Tao, K. Schaible, C. Wylie, and J. Heasman The roles of three signaling pathways in the formation and function of the Spemann Organizer Development, September 1, 2002; 129(17): 4027 - 4043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhao, S. E. Harris, D. Horn, Z. Geng, R. Nishimura, G. R. Mundy, and Di Chen Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation J. Cell Biol., June 10, 2002; 157(6): 1049 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shimizu, P.-Y. Bourillot, S. J. Nielsen, A. M. Zorn, and J. B. Gurdon Swift Is a Novel BRCT Domain Coactivator of Smad2 in Transforming Growth Factor {beta} Signaling Mol. Cell. Biol., June 15, 2001; 21(12): 3901 - 3912. [Abstract] [Full Text]
|
|
|
|
|
|
S Faure, M. Lee, T Keller, P ten Dijke, and M Whitman Endogenous patterns of TGFbeta superfamily signaling during early Xenopus development Development, January 7, 2000; 127(13): 2917 - 2931. [Abstract] [PDF]
|
|
|
|
 |
|
 S. J. Newfeld, R. G. Wisotzkey, and S. Kumar Molecular Evolution of a Developmental Pathway: Phylogenetic Analyses of Transforming Growth Factor-ß Family Ligands, Receptors and Smad Signal Transducers Genetics, June 1, 1999; 152(2): 783 - 795. [Abstract] [Full Text]
|
|
|
|
|
|
M Nikaido, M Tada, H Takeda, A Kuroiwa, and N Ueno In vivo analysis using variants of zebrafish BMPR-IA: range of action and involvement of BMP in ectoderm patterning Development, January 1, 1999; 126(1): 181 - 190. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Macias-Silva, P. A. Hoodless, S. J. Tang, M. Buchwald, and J. L. Wrana Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2 J. Biol. Chem., October 2, 1998; 273(40): 25628 - 25636. [Abstract] [Full Text] [PDF]
|
|
